Skip to main content

Advocating for Patients

It Never Should Have Happened: Recognizing Racial Bias in Asthma Could Have Saved Valerie’s Husband

On Sept. 16, 2020, the Asthma and Allergy Foundation of America (AAFA) released our Asthma Disparities in America report. This report looks at how asthma affects Black, Hispanic and American Indian/Alaska Native groups in the United States. After coming across this report, Valerie Vison reached out to share her story. In the essay below, you’ll hear from Valerie, who lost her husband, Jordan, to asthma on July 22. In a World of “What If” – Could Racial Bias Have Contributed to My 30-Year-Old...

Asthma Impacts on American Indian/Alaska Native People

The Asthma and Allergy Foundation of America report on Asthma Disparities in America looks at the burden of asthma on racial/ethnic groups in the United States. Health disparities are preventable health differences between groups of people. Health disparities are higher burdens of illness or death linked to social, economic, and environmental disadvantages. For example, if one group of people has a higher rate of asthma than another group of people, it is an asthma disparity. This month is...

AAFA and Other Groups Ask New Administration to Protect People With Pre-Existing Conditions

The countdown to Inauguration Day has begun. The Asthma and Allergy Foundation of America (AAFA) has joined 32 patient groups to represent millions of people with pre-existing conditions. We are urging lawmakers to spend their first 100 days in office working to make sure people have access to high-quality, affordable health coverage. “ The 100 Days Agenda: A Patient-First Blueprint ” outlines specific steps the president and other elected officials can take to protect patients. The first...

AAFA Receives CDC Funding Award to Improve Asthma Care and Outcomes for At-Risk Populations Through Comprehensive Community Health Interventions

The Asthma and Allergy Foundation of America (AAFA) is spearheading yet another new venture geared toward improving health outcomes for our nation’s most at-risk groups affected by asthma. These groups include Black, Hispanic and Indigenous Americans, senior adults, expectant mothers, children with asthma, and our nation’s military who have developed asthma while in service.

House Passes Bill Protecting Students With Asthma and Allergies, Moves to Senate for Vote

Update: It's official! On Jan. 5, 2021, the president signed the School-Based Allergies and Asthma Management Program Act into law. Thank you to our community. Your efforts helped to get this bill signed into law, which will help thousands of students with asthma and allergies and their families nationwide. On Sept. 29, 2020, the House of Representatives passed the School-Based Allergies and Asthma Management Program Act (H.R. 2468) . If passed by the Senate and signed into law by the...

Asthma Disparities in America: It’s Time for Real and Lasting Change

Black, Hispanic and American Indian/Alaska Native people have the highest rates of asthma , hospital visits and asthma-related deaths. This has not changed since we first reported on it in 2005. It’s time to take bold steps to reduce disparities in asthma. Asthma Disparities in America Report Today, the Asthma and Allergy Foundation of America (AAFA) released its Asthma Disparities in America report. This report looks at how asthma affects Black, Hispanic and American Indian/Alaska Native...

Advocacy Update: Funding for Asthma Programs and Food Allergy Research, Protections for Students, and Action on Sesame Allergy

Great Strides in July 2020 for People With Asthma and Allergies AAFA has made great strides this month in advocating for policies that protect people with asthma and allergies. The House Energy and Commerce Committee passed the School-Based Allergies and Asthma Management Program Act (H.R. 2468) and the Food Allergy Safety, Treatment, Education, and Research (FASTER) Act (H.R. 2117) . These have been top priority issues for our organization and we're excited for this progress! UPDATE...

Asthma and Allergy Research With You as an Equal Partner

The Asthma and Allergy Foundation of America (AAFA) conducts and promotes patient-centered research to help you. This means your beliefs, preferences and needs are at the center of our research. Your input drives our advocacy work, guides our education programs and supports our community. Recently, we’ve studied the following topics: Symptoms of anaphylaxis in infants and toddlers Eczema burdens and people’s experiences with treatments Impact of COVID-19 on people with asthma and allergy Air...

Letter to the FDA: Require Food Manufacturers to Post Substitutions

On May 22, 2020, the Food and Drug Administration (FDA) relaxed labeling guidelines for food companies . This is a temporary measure because of food supply issues due to COVID-19 (the new coronavirus). The Asthma and Allergy Foundation of America (AAFA) met with the FDA to talk about how this will affect the food allergy community. After the meeting, we organized a joint letter with other food allergy advocacy organizations to send to the FDA. The letter addresses the FDA’s short-term food...

Congress Recognizes May as National Asthma and Allergy Awareness Month

The U.S. House of Representatives has declared their support for National Asthma and Allergy Awareness Month . Reps. Eliot Engel (D-NY), Fred Upton (R-MI), TJ Cox (D-CA) and Peter King (R-NY) submitted the resolution to the House Committee on Energy and Commerce on May 8, 2020. May is peak season for people with asthma and allergies. That’s why the Asthma and Allergy Foundation of America (AAFA) chose it as a time to raise awareness and educate people on how to manage these conditions. Read...

COVID-19 and Its Impact on People With Asthma and Allergies: A Global Health Crisis

The Asthma and Allergy Foundation of America (AAFA) has been fighting to save lives for nearly 70 years. With your support, we provide education, conduct patient-centered research and advocate for protections for our community. Our experience and strong community ties allowed us to take prompt action on the COVID-19 crisis . Thanks to your generous support, we are leading the fight against COVID-19 for people with asthma and allergies. But we need your help to continue to provide COVID-19...

Asthma and Allergy Caucus to FDA: Take Action to Prevent Albuterol Shortages

Congressmen Eliot L. Engel (D-NY) and Fred Upton (R-MI), Co-Chairs of the Asthma and Allergy Caucus, joined by Congressmen TJ Cox (D-CA) and Peter King (R-NY), Members of Caucus, led 57 Members of the House on a letter to the Food and Drug Administration (FDA) about shortages of albuterol inhalers, which are critical to effective asthma management.

Asthma Drug Shortages During COVID-19: A Letter From AAFA’s President and CEO

Because of the COVID-19 (new coronavirus) pandemic, we are facing a challenging and unprecedented time. COVID-19 is a respiratory infection, and the nearly 25 million Americans with asthma are at high risk for complications from the virus. As the leading patient organization for people with asthma and allergies, this has the Asthma and Allergy Foundation of America (AAFA) deeply concerned for your health and well-being.

Emotional Support Animals on Planes: AAFA Submits Comment to the DOT

Update: On Dec. 2, 2020, the Department of Transportation (DOT) posted their final rule on “ Traveling by Air with Service Animals .” The rule will allow airlines to treat emotional support animals as pets. The DOT acknowledged AAFA’s comments. They said they felt the rule will likely reduce the number of uncrated animals on planes, so that would reduce the number of potential allergic reactions and asthma episodes. AAFA expressed support for the core proposal. But we are disappointed that...

×
×
×
×